|
PROSTAGLANDIN E1 |
|||
PRODUCT IDENTIFICATION |
|||
CAS NO. | 745-65-3 |
|
|
EINECS NO. | 212-017-2 | ||
FORMULA | C20H34O5 | ||
MOL WT. | 354.49 | ||
H.S. CODE |
2918.99.5000 | ||
TOXICITY |
Oral Rat LD50: 228mg/kg | ||
SYNONYMS | Alprostadil; GE1; Prostaglandin E1; Prostin; Femprox; Lipoprost; | ||
11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost- 13-enoic acid; 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid; (11alpha,13E, 15S)-11,15-dihydroxy-9-oxo-prost-13 -en-1-oic acid ; l-PGE1; l-Prostaglandin E1; l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; Alprostadilum; Other RN: 50-83-9, 22299-37-2, 50865-30-0 | |||
SMILES | CCCCC[C@@H](/C=C/C1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O | ||
CLASSIFICATION |
Cardiovascular, Fibrin Modulator, Fibrinolytic, Hematologic, Platelet aggregation inhibitor, Vasodilator |
||
EXTRA NOTES |
A potent vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, etc. | ||
PHYSICAL AND CHEMICAL PROPERTIES |
|||
PHYSICAL STATE | white to yellow crystalline solid | ||
MELTING POINT | 115 - 116 C | ||
BOILING POINT | |||
SPECIFIC GRAVITY | |||
SOLUBILITY IN WATER |
Partly soluble |
||
SOLVENT SOLUBILITY | Soluble in ethanol, methanol, ethyl acetate. Acetone 10g/l at 25 C | ||
pKa | 4.85 ( Dissociation Constant) | ||
log P |
3.2 |
||
VAPOR DENSITY |
|
||
AUTOIGNITION |
|
||
NFPA RATINGS |
Health hazard: 2, Flammability: 0, Physical hazards: 0 |
||
REFRACTIVE INDEX |
|||
FLASH POINT |
|
||
STABILITY |
Stable under ordinary conditions. |
||
EXTERNAL LINKS & GENERAL DESCRIPTION |
|||
Drug Information Portal (U.S. National Library of Medicine) - Alprostadil PubChem Compound Summary - Prostaglandin E1 Drug Bank - Alprostadil KEGG (Kyoto Encyclopedia of Genes and Genomes) - Prostaglandin E1 http://www.ebi.ac.uk/chebi/ - Prostaglandin E1 http://www.ncbi.nlm.nih.gov/ - Prostaglandin E1 Human Metabolome Database - Prostaglandin E1 http://www.sigmaaldrich.com/ Local Prostaglandin belongs to eicosanoids, biologically active 20-carbon substances including prostaglandins, thromboxanes, prostacyclins, and leukotrienes. Eicosanoids are oxygenated hydrophobic cytokines, small proteins that are the core of communication between immune systems. Prostaglandins, thromboxanes, prostacyclins are derived via the cyclooxygenase pathway, while leukotrienes are via 5-lipoxygenase pathway. Prostaglandins are eicosanoids having a cyclopentane ring. Prostaglandins have two double bonds typically, while leukotrienes have four. Prostaglandins act in the cells in which they are synthesized and surrounding cells, and their actions and effects vary with concentration, hormonal environment, and cell type. Prostaglandins mediate a wide range of physiological functions, such as control of blood pressure, regulation of muscle, glandular secretion, transmission of nerve impulses, and modulation of inflammation. Specific Prostaglandins designated by adding a letter on PG (the abbreviation for prostaglandin) to indicate the type of ring structure and a numerical subscript to indicate the number of double bonds. The subscript alpha or beta indicates the three-dimensional configuration of alcoholic groups attached to the ring structures. Alpha denotes a substituent below the plane of the ring, beta, above the plane.
|
|||
SALES SPECIFICATION | |||
APPEARANCE |
white to off-white crystalline powder | ||
ASSAY |
99.0 % min |
||
TRANSPORTATION | |||
PACKING |
|
||
HAZARD CLASS | 6.1 (Packing Group: III) | ||
UN NO. | 2811 | ||
SAFETY INFORMATION | |||
HAZARD OVERVIEW |
OSHA Hazards:Target Organ Effect, Toxic by ingestion, Teratogen Target Organs: Smooth muscle., Heart |
||
GHS |
|
||
SIGNAL WORD | Danger | ||
PICTOGRAMS |
|
||
HAZARD STATEMENTS |
H301-H361 |
||
P STATEMENTS |
P281-P301 + P310 |
||
EC DIRECTIVES |
|
||
HAZARD CODES |
|
||
RISK PHRASES |
22 |
||
SAFETY PHRASES |
36 |
||
PRICE INFORMATION | |||
|
|